BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1683186)

  • 1. Single administration of captopril and combined use with beta-blocker and/or thiazide diuretic in the treatment of essential hypertension.
    Yoneda S; Kako T; Koketsu M; Hayano J; Asakawa T; Fujinami T; Kato T
    Angiology; 1991 Nov; 42(11):914-23. PubMed ID: 1683186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial.
    Wilhelmsen L; Berglund G; Elmfeldt D; Fitzsimons T; Holzgreve H; Hosie J; Hörnkvist PE; Pennert K; Tuomilehto J; Wedel H
    J Hypertens; 1987 Oct; 5(5):561-72. PubMed ID: 2892881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of captopril and enalapril in mild to moderate hypertension.
    Vlasses PH; Conner DP; Rotmensch HH; Fruncillo RJ; Danzeisen JR; Shepley KJ; Ferguson RK
    J Am Coll Cardiol; 1986 Mar; 7(3):651-60. PubMed ID: 3005384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice-daily low-dose captopril in diuretic-treated hypertensives.
    Murdoch DL; Gillen GJ; Morton JJ; Leckie B; Murray GD; Davies DL; McInnes GT
    J Hum Hypertens; 1989 Feb; 3(1):29-33. PubMed ID: 2657056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
    Fujita T; Ando K; Noda H; Sato Y; Yamashita N; Yamashita K
    Am J Med; 1982 Sep; 73(3):341-7. PubMed ID: 6751080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of captopril and thiazide diuretic on serum lipid profile in hypertensive women.
    Karim S; Karim S; Begum A; Javed N
    J Ayub Med Coll Abbottabad; 2001; 13(1):19-21. PubMed ID: 11706633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of renin levels on the treatment of essential hypertension with thiazide diuretics.
    Wyndham RN; Gimenez L; Walker WG; Whelton PK; Russell RP
    Arch Intern Med; 1987 Jun; 147(6):1021-5. PubMed ID: 3296978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of indapamide with thiazide diuretics in patients with essential hypertension.
    Chalmers JP; Bune AJ; Graham JR; West MJ; Wing LM
    Med J Aust; 1981 Jul; 2(2):100-1. PubMed ID: 7300705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S77-81. PubMed ID: 2580181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of captopril-thiazide and enalapril-thiazide combinations in the management of mild to moderate black hypertensive patients: how important is diuretic dose and duration of action of the ACE-inhibitor?
    Skoularigis J; Strugo V; Zambakides C; Eintracht S; Reddy K; Tshele E; Smith D; Sareli P
    Int J Clin Pharmacol Ther; 1996 Jun; 34(6):263-8. PubMed ID: 8793612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden.
    Samuelsson O; Hedner T; Berglund G; Persson B; Andersson OK; Wilhelmsen L
    J Hum Hypertens; 1994 Apr; 8(4):257-63. PubMed ID: 7912734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood pressure responses of thiazide-resistant hypertensives to a once-a-day bevantolol regimen.
    Snedden W; Fernandez PG; Nath C
    Can J Cardiol; 1987 Oct; 3(7):322-5. PubMed ID: 2892582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.
    Ishimitsu T; Numabe A; Masuda T; Akabane T; Okamura A; Minami J; Matsuoka H
    Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute titration and chronic follow-up with captopril in hypertension. A one-year safety profile on combination therapy with captopril and a diuretic.
    Mahapatra D; Mahapatra RK; Yaden S; Hunter KW
    Angiology; 1986 Dec; 37(12 Pt 1):865-79. PubMed ID: 2880534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and neurohumoral factors in the response of hypertensives to hydrochlorothiazide therapy.
    Fernandez PG; Snedden W; Nath C; Vasdev S; Lee C; Darke A
    Clin Invest Med; 1987 Nov; 10(6):513-9. PubMed ID: 3326694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.